STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,329,283 | -63.5% | 591,117 | -1.4% | 0.00% | -100.0% |
| Q2 2023 | $6,375,661 | +57.3% | 599,780 | +23.2% | 0.00% | 0.0% |
| Q1 2023 | $4,054,044 | +92521.5% | 486,680 | +2.6% | 0.00% | 0.0% |
| Q4 2022 | $4,377 | -99.9% | 474,224 | +3.0% | 0.00% | 0.0% |
| Q3 2022 | $5,909,000 | +0.8% | 460,255 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $5,862,000 | -36.1% | 443,809 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $9,172,000 | +1.7% | 435,771 | +15.8% | 0.00% | 0.0% |
| Q4 2021 | $9,023,000 | -2.4% | 376,154 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $9,243,000 | -22.9% | 363,335 | +2.0% | 0.00% | -50.0% |
| Q2 2021 | $11,991,000 | +5.4% | 356,246 | +21.6% | 0.00% | 0.0% |
| Q1 2021 | $11,381,000 | -32.2% | 293,036 | +8.1% | 0.00% | -33.3% |
| Q4 2020 | $16,793,000 | +148.0% | 271,165 | +34.1% | 0.00% | +200.0% |
| Q3 2020 | $6,771,000 | +77.7% | 202,189 | +26.4% | 0.00% | 0.0% |
| Q2 2020 | $3,811,000 | -10.5% | 159,944 | -13.9% | 0.00% | 0.0% |
| Q1 2020 | $4,256,000 | -37.2% | 185,856 | -22.4% | 0.00% | 0.0% |
| Q4 2019 | $6,780,000 | +179.8% | 239,434 | +112.4% | 0.00% | 0.0% |
| Q3 2019 | $2,423,000 | – | 112,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |